Impact of enteral protein supplementation in premature infants by Barrus DM et al.
© 2012 Barrus et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article  
which permits unrestricted noncommercial use, provided the original work is properly cited.
Research and Reports in Neonatology 2012:2 25–31
Research and Reports in Neonatology
Impact of enteral protein supplementation  
in premature infants
David M Barrus1
Joann Romano-Keeler2
Christopher Carr3
Kira Segebarth4
Betty Claxton2
William F Walsh2
Paul J Flakoll5
1Department of Neonatology,  
Saint Francis Hospital–Bartlett, 
Memphis, TN, 2Department  
of Pediatrics, Vanderbilt Medical 
Center, Nashville, TN, 3Department of 
Surgery, Naval Hospital Bremerton, 
Bremerton, WA, 4Pediatric and 
Diabetes Specialists, Carolinas Medical 
Center, Charlotte, NC, 5Department 
of Surgery, Vanderbilt Medical Center, 
Nashville, TN, USA
Correspondence: Joann Romano-Keeler 
Monroe Carell Jr Children’s Hospital at 
Vanderbilt, 2200 Children’s Way, Nashville, 
TN 37232, USA 
Tel +1 615 936 8953 
Fax +1 615 343 1763 
Email joann.romano-keeler@vanderbilt.edu
Objective: The quantity of enteral protein supplementation required by premature infants to 
optimize growth has not been determined. This study compares the growth of premature infants 
fed the current standard intake of protein (3.5 g/kg/day) with the growth of those fed a higher 
amount (4.0 g/kg/day).
Study design: Fifty-two infants ,1500 g and ,33 weeks gestational age participated in a 
blinded, single-center, prospective randomized control trial to compare growth between two 
groups of different protein-intake levels. Primary outcomes were average daily weight gain 
(g/kg/day), head-circumference (cm/kg/week) and linear growth velocity (cm/kg/week). 
  Secondary outcomes were serum indices of protein tolerance and plasma amino acid 
concentrations.
Results: Infants receiving higher amounts of protein had higher rates of growth for body weight 
(18.2 ± 0.7 versus 16.2 ± 1.0 g/kg/day; P , 0.05) and head circumference (0.87 ± 0.08 versus 
0.62 ± 0.07 cm/kg/week; P , 0.05), with no differences in blood protein or plasma amino 
acid concentrations. Length of hospital stay was 14 days shorter for the higher-protein group 
(51.4 ± 4.0 versus 65.9 ± 6.3 days).
Conclusion: Increasing premature infant enteral protein supplementation from a calculated 
intake of 3.5–4.0 g/kg/day improved growth in a safe manner.
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Introduction
The optimal intake of protein and other nutrients by premature infants has been a 
long-debated topic. The nutritional goal for premature infants is to provide an environ-
ment to help them grow at rates comparable to those they would experience in utero. 
Rarely do premature infants achieve this growth rate during their initial hospital stay. 
Evaluation of the outcomes of very low birth-weight infants in the National Institute 
of Child Health and Human Development Neonatal Research Network demonstrated 
that 79% of these infants had restricted growth at 36 weeks corrected age.1 Early 
growth deficits have significant implications, as they have been linked to long-term 
growth failure, including subnormal head circumferences, which often serve as an 
indirect marker of brain development. This blunted postnatal brain growth has been 
correlated with poorer neurologic outcomes, including decreased intelligence quotients 
and adaptive behavior skills.2–4
While specific protein requirements for premature infants have not been established 
in controlled systematic studies, it is clear that preterm human milk provides insuf-
ficient5–7 and highly variable8 quantities of protein to meet the needs of the growing 
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preterm infant. Premature infants receiving preterm-infant 
formula9–11 and human milk12,13 supplemented with protein 
were demonstrated to have increased growth versus those 
fed human breast milk alone. A recent study examining dif-
ferent levels of protein intake in preterm infants found that 
higher levels of up to 3.3 g/kg/day were safe and associated 
with improved weight gain before initial hospital discharge.14 
However, balancing the beneficial role of high protein intake 
with its deleterious effects remains enigmatic. There is no 
consensus on the optimal daily protein concentration for this 
at-risk population.
Because the protein content of human milk varies not 
only between women but also from day to day and even 
within each feed, a calculated average protein and calorie 
concentration is used by most studies requiring these values. 
One of these studies compared growth rates among preterm 
infants receiving two human milk fortifiers varying in pro-
tein content,15 and again found the highest rates of growth in 
those babies receiving the higher protein intake. Because of 
these results, the current standard of practice at Vanderbilt 
University Hospital and other hospitals is to feed protein at 
3.5 g/kg/day.
The objective of this study was to determine the differ-
ence in growth rates in premature infants receiving calculated 
average enteral protein intakes of 3.5 versus 4.0 g/kg/day, 
while varying only the protein intake between the two groups. 
The primary outcomes followed were measurements of 
growth, including weight, length and head circumference. 
Secondary outcomes were measurements of morbidity and 
blood markers of protein tolerance.
Materials and methods
Subjects
Approval for this study was obtained from Vanderbilt 
  University’s Institutional Review Board. Babies were eligible 
for this study if their birth weights were less than 1500 g and 
gestational ages were less than 33 weeks. In addition, they were 
required to be free from growth-affecting anomalies, includ-
ing gastrointestinal malformations, necrotizing enterocolitis, 
cardiac disorders excluding a history of patent ductus arterio-
sus and hydrocephalus requiring shunting. Participation was 
restricted to those babies whose feedings were initially breast 
milk. For this single-center study, 60 qualified babies were 
identified, parental consent was obtained and their assigned 
protein-intake regimen was initiated when each baby reached 
full-volume feeds (130–150 mL/kg/day), as determined by 
their medical team, and completed all parenteral protein 
supplementation. Babies completed the study when they 
reached 1800 g or when they were discharged home or to an 
affiliated hospital. Babies were withdrawn from the study 
early if they were unable to continue feeds totaling at least 
100 mL/kg/day for 72 hours. It was determined a priori that 
babies participating in the study for less than 8 days would 
not be included in the final data analysis.
Design
This study was a blinded, prospective randomized control trial 
comparing growth rates of preterm infants receiving enteral 
protein intakes calculated to be 3.5 versus 4.0 g/kg/day. 
Breast-milk feedings fortified to 3.5 g/kg/day were prepared 
by mixing four packets of human milk fortifier (Similac 
HMF; Ross Laboratories, Columbus, OH) and 0.5 g/kg/day 
of powdered modular protein supplement (ProMod; Abbott 
Laboratories Ross Products Division, Columbus, OH) with 
100 mL of breast milk. Those fortified to 4.0 g/kg/day were 
prepared by mixing four packets of HMF and 1.0 g/kg/day 
of powdered modular protein supplement of ProMod with 
100 mL of breast milk. The quantity of modular protein 
added to each group’s feeds was dependent upon the daily 
volume intake to ensure the protein intake remained consis-
tent with a baby’s assigned intake group. The supplements 
were premeasured daily for each specific baby and placed in 
coded containers at the bedside to be mixed with their feeds. 
Differences between groups’ coded tubes were not discern-
ible to the naked eye. If breast milk was not available for a 
feed, a standard premature-infant formula (Similac Special 
Care 24; Abbott Laboratories Ross Products Division) was 
supplemented to the appropriate protein levels of 3.5 and 
4.0 g/kg/day with modular protein of 0.5 and 1.0 g/kg/day, 
respectively.
There were three principal investigators involved with 
randomization of patients. Prior to the initiation of the 
study, a set of opaque envelopes was created with patient 
assignments as control or treatment. These envelopes were 
opened by the study nutritionist, who prepared the appropri-
ate formula for the patient with the hospital nutrition team. 
The study nutritionist provided feedings in coded tubes to 
the three principal investigators, who were responsible for 
distributing them to the patients’ bedside nurses. These bed-
side nurses were also blinded to the patients’ assignments to 
low- or high-protein intake.
Measurements
The primary outcome measured was infant growth. Daily 
body weight estimated to the nearest gram and weekly head 
circumference to the nearest 0.25 cm were measured by 
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trained neonatal bedside nurses as per the unit’s   standardized 
protocol. They also recorded weekly recumbent length, 
measured to the nearest 0.25 cm with a nonstretchable tape. 
Growth rates for each infant were calculated using that 
infant’s average measurement for that parameter. Serum was 
analyzed from blood collected by venous puncture upon entry 
into the study and biweekly thereafter. The serum indices 
measured were total protein, albumin, pH, hematocrit and 
blood urea nitrogen by the Vanderbilt University Hospital 
laboratory. Plasma amino acid concentrations were deter-
mined by reversed-phase high-performance liquid chroma-
tography after derivatization with phenylisothiocynate16 in 
the investigators’ laboratory.
Sample size calculations and  
statistical methods
We considered a 10% difference in growth rates, including 
linear and head-circumference velocity as well as average 
daily weight gain, between the two groups as clinically 
significant. To identify a difference of this size with respect 
to all three growth parameters between the low- and high-
protein group, we required a sample size of 30 babies per 
intake group, based on a standard deviation of 13.5% and 
our power calculations (0.05 for type I error probability and 
0.80 for power). Data analysis consisted of a comparison 
of an experimental (high protein intake) versus a control 
(standard protein intake) group using an analysis of   variance 
and a Student’s t-test with the Statistical Analysis System 
(SAS Institute, Cary, NC). Differences between the treat-
ment groups for gender and race were assessed using chi-
squared analysis (SAS). Statistical significance level was 
set at P , 0.05. Values presented in the text and tables are 
means ± structural equation modeling.
Results
Subjects
Sixty patients were recruited for the study, 30 per treatment 
group. Initial measurements from the study population 
are included in Table 1. The range in birth weight was 
550–1475 g in the control group and 620–1369 g in the 
experimental group. Infants of multiple births were ran-
domized separately, and the mean number of offspring at 
parity was not different. There was a difference in gender 
composition between groups, with the control group hav-
ing more males and the experimental group having more 
females. Four babies from each treatment group were on 
treatment less than 8 days and were excluded from data 
analysis. Though five of the 52 participants had a 72-hour 
period of feeding   intolerance at volumes of 100 mL/kg/day, 
all five of them were still included in the study, since 
they had already completed at least 8 days on the study-
feeding protocols. The reasons for intolerance are shown 
in Table 2.
growth
Rates of growth are included in Table 3. The rate of weight 
gain (g/kg/day) was 12% higher, and head-  circumference gain 
was 40% higher for the experimental group.   Longitudinal 
growth rate (cm/kg/week) was 15% greater in the group 
receiving the higher protein, but this was not statistically 
significant.
Table 2   Reasons  for  infant  intolerance  to  feeding  (number 
of infants)
Condition Control Experimental
Necrotizing enterocolitis 
Septic ileus 
Other ileus
2 
1 
0
0 
1 
1
Table 1 Initial study population measurements
Control Experimental
n 26 26
gestational age (weeks) 27.9 ± 0.4 27.8 ± 0.3
Birth weight (g) 1008 ± 43 1062 ± 42
Number of IUgR infants 1 1
Sex (M:F) 16:10 7:19*
Race 
  Non-Hispanic white 
  African-American 
  Hispanic
 
17 
5 
4
 
20 
5 
1
Median 1-minute Apgar  
(25th, 75th percentile)
7 
(3, 8)
5 
(2, 6)
Median 5-minute Apgar  
(25th, 75th percentile)
7 
(6, 8)
7 
(5, 8)
Days to first feed 2.9 ± 0.4 3.5 ± 0.6
Days to 100 mL/kg/day 20.1 ± 10.7 15.2 ± 6.7
Weight at day 0 1224 ± 42 1203 ± 40
Days on study 20.4 ± 2.1 19.4 ± 2.0
Patients on ventilator 18 18
Days on ventilator 9.7 ± 3.0 5.6 ± 1.9
Note: *P , 0.05 difference from 3.5 g/kg/day group.
Abbreviation: IUgR, intrauterine growth restriction.
Table 3 growth rates
Control Experimental
Weight (g/kg/day) 16.2 ± 1.0 18.2 ± 0.7*
Length (cm/kg/week) 0.92 ± 0.14 1.06 ± 0.13
Head circumference (cm/kg/week) 0.62 ± 0.07 0.87 ± 0.08*
Note: *P , 0.05 difference from 3.5 g/kg/day group.
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Nutrient intake and days hospitalized
Volume intake, caloric density and caloric intake were 
similar between groups (Table 4). The experimental group 
tended to have more of their total-volume intake in the 
form of breast milk. The total days hospitalized were 22% 
less (14 days) in the group receiving the higher-protein 
intake.
Blood measurements
Baseline and subsequent laboratory values were measured 
to evaluate the safety of the two protein intakes and are 
displayed in Tables 5 and 6. None of the values differed 
between intake groups. Plasma amino acid concentrations, 
either individually or grouped as branched-chain amino 
acids, essential amino acids, nonessential amino acids or 
total amino acids were not different with increased protein 
intake.
Table 4 Nutritional intake and days hospitalized
Control Experimental
Volume intake (mL/kg/day) 140.2 ± 3.0 140.4 ± 2.7
% Breast milk 
(average % breast milk/day)
51.6 ± 8.3 69.7 ± 7.3*
Days nil per oral per infant 0.12 0.31
Hospitalization (days) 65.9 ± 6.3 51.4 ± 4.0*
Note: *P , 0.05 difference from 3.5 g/kg/day group.
Table 5 Serum indices
Control Experimental
Blood urea nitrogen 
(mmol/L (mg/dL))  
  Day 0 
  Day 14
 
 
3.53 ± 0.39 (9.9 ± 1.1) 
2.00 ± 0.32 (5.6 ± 0.9)
 
 
3.39 ± 0.32 (9.5 ± 0.9) 
2.61 ± 0.25 (7.3 ± 0.7)
Total serum protein 
(g/L (g/dL))  
  Day 14
 
51 ± 1.0 (5.1 ± 0.1) 
48 ± 1.0 (4.8 ± 0.1)
 
49 ± 1.0 (4.9 ± 0.1) 
46 ± 1.0 (4.6 ± 0.1)
Albumin  
(g/L (g/dL)) 
  Day 0 
  Day 14
 
 
28 ± 1.0 (2.8 ± 0.1) 
26 ± 1.0 (2.6 ± 0.1)
 
 
28 ± 1.0 (2.8 ± 0.1) 
25 ± 1.0 (2.5 ± 0.1)
pH  
  Day 0 
  Day 14
 
7.38 ± 0.01 
7.38 ± 0.01
 
7.35 ± 0.01 
7.36 ± 0.02
pCO2 (mm Hg)  
  Day 0 
  Day 14
 
47.2 ± 2.2 
46.6 ± 2.7
 
48.1 ± 2.2 
49.6 ± 3.4
Hematocrit (%)  
  Day 0 
  Day 14
 
38.1 ± 0.9 
32.7 ± 1.0
 
37.1 ± 1.2 
32.5 ± 1.2
Note: There were no significant differences between protein-intake groups for any 
of these variables at either week 1 or 3.
Table 6 Plasma amino acid concentrations (μmol/L)
Control Experimental
1-Methylhistidine 0.3 ± 0.3 0.5 ± 0.3
3-Methylhistidine 3.2 ± 0.6 5.0 ± 1.1
Alanine 682 ± 88 613 ± 78
Arginine 10.1 ± 1.4 16.1 ± 4.8
Asparagine 58.4 ± 5.1 63.6 ± 6.3
Aspartate 62.2 ± 6.6 57.2 ± 6.4
Citrulline 31.2 ± 3.3 30.6 ± 3.3
glutamate 184 ± 35 213 ± 47
glutamine 383 ± 44 371 ± 38
glycine 434 ± 39 411 ± 34
Histidine 67.5 ± 6.3 61.9 ± 5.6
Hydroxyproline 107.6 ± 7.6 108.8 ±6.8
Isoleucine 42.4 ± 3.1 45.6 ± 4.1
Leucine 85.3 ± 4.3 85.6 ± 5.8
Lysine 202 ± 14 195 ± 19
Methionine 28.7 ± 1.8 31.4 ± 1.2
Ornithine 197 ± 22 168 ± 19
Phenylalanine 46.6 ± 3.7 47.5 ± 2.7
Proline 252 ± 15 257 ± 21
Serine 252 ± 30 224 ± 29
Taurine 317 ± 26 288 ± 29
Threonine 223 ± 22 223 ± 25
Tryptophan 28.9 ± 1.9 25.4 ± 2.4
Tyrosine 119 ± 14 107 ± 12
Valine 131 ± 7 131 ± 11
Branched chain 259 ± 13 262 ± 19
Essential 865 ± 47 861 ± 61
Nonessential 3056 ± 220 2895 ± 214
Total 3920 ± 259 3756 ± 258
Notes:  Values  (μmol/L)  are  reported  as  the  mean  ±  structural  equation 
modeling for each group. Blood samples in the infants were taken 7–10 days 
after  initiation  of  the  experiment.  There  were  no  differences  between  the   
two groups of infants.
Discussion
It has been shown that protein supplementation of preterm 
breast milk results in improved growth in premature infants. 
The optimal quantity of protein supplementation in preterm 
infants, however, has not been defined. Based upon recent 
data, several neonatal care units have used a calculated 
protein intake of 3.5 gm/kg/day as the standard of care for 
this population.
The present study compared the standard protein intake 
with a higher calculated intake of 4 gm/kg/day and found 
that all parameters of growth measured were improved with 
the increased protein intake. Although these rates of growth 
are still slightly below that previously found in utero,17 the 
increased growth was of a magnitude that was both statisti-
cally and clinically significant (except length). Importantly, 
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the increase in growth was obtained without increasing 
infant morbidity or mortality. Furthermore, the period of 
hospitalization in this study was reduced by about 14 days 
with the higher protein, which would have considerable 
economic impact.
It was interesting that an increase in protein intake 
by 0.5 g/kg/day led to an increase in body weight of 
2 g/kg/day. Olsen et al18 reported comparable accelerated 
growth   velocities of greater than 4 g/kg/day with an addi-
tional 1 g/kg/day of protein. Studies of protein kinetics in 
Figure 1 The interaction of birth weights with daily body-weight (A) and head-circumference (B) growth rates. Babies with birth weights less than 1000 g are included on 
the left, and babies with birth weights between 1000 and 1500 g are included on the right.
Notes: *P , 0.05 difference from 3.5 g/kg/day group within the same birth-weight range. Usual custom is 1000 g or less and 1001–1500 g.
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preterm infants19 have demonstrated that nitrogen balance 
improves linearly during incremental increases in protein 
intake from 0.8 to 3.5 g/kg/day.19 Furthermore, rates of 
flux or oxidation for marker amino acids are unaffected by 
these increases in protein intake, indicative of the contin-
ued ability of these infants to metabolize a higher protein 
load. Taken together, the linearity of these data suggests 
that the optimal intake of protein may likely be greater 
than 3.5 g/kg/day.
It is possible that protein requirements may be different 
at each stage of growth. While this study was not designed 
with the power to address this question, some insight can 
be gained from these data. When body-weight and head-
circumference growth data are grouped according to ranges 
in birth weight (Figure 1A and B), it is interesting to note 
that the differences in body-weight gain between the 3.5 and 
4.0 g/kg/day protein intake were greater in the infants with 
birth weights less than 1000 g (20% increase), as opposed 
to the infants with birth weights between 1000 and 1500 g 
(5% increase). While more research is needed, this would 
suggest that the lower-birth-weight infants may have greater 
protein intake requirements.
Two factors that did differ between the two groups were 
the infants’ gender and the amount of breast milk received. 
Previous research has shown that (1) preterm male infants 
had higher growth rates than females,21 and (2) infants fed 
breast milk grew more slowly than infants fed formula.10 
Therefore, consideration of these variables would suggest 
that this study provides a conservative estimate of the effects 
of protein supplementation, and the increases noted may have 
been larger if gender and amount of breast milk received 
were equivalent. A limitation of this study includes the lack 
of adjustment for multiple comparisons, despite the different 
outcomes that were analyzed. Inclusion of these adjustments 
would have diminished the statistical significance of our 
results, though omission may have increased the probability 
of false positives.
In conclusion, increased calculated protein intake in pre-
mature infants from 3.5 to 4.0 g/kg/day resulted in clinical 
improvements in growth without changes in morbidity or 
mortality. The benefits and safety of protein intakes greater 
than 4.0 g/kg/day are still unclear. The results of this study 
may lead to additional research that would allow us to define 
the optimal level of protein intake and its importance in this 
at-risk population. Finally, a better understanding of the 
relationship between increased growth as a result of increased 
protein intake and long-term cognitive development would 
help our understanding of the importance of these findings.
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